Last reviewed · How we verify

Anti-pandemic H1N1 influenza vaccine

University of Sao Paulo · FDA-approved active Biologic

Anti-pandemic H1N1 influenza vaccine is a inactivated influenza vaccine Biologic drug developed by University of Sao Paulo. It is currently FDA-approved for Prevention of H1N1 influenza infection during pandemic periods.

The vaccine stimulates the immune system to produce antibodies and cellular immunity against H1N1 influenza virus antigens.

The vaccine stimulates the immune system to produce antibodies and cellular immunity against H1N1 influenza virus antigens. Used for Prevention of H1N1 influenza infection during pandemic periods.

At a glance

Generic nameAnti-pandemic H1N1 influenza vaccine
SponsorUniversity of Sao Paulo
Drug classinactivated influenza vaccine
ModalityBiologic
Therapeutic areaImmunology
PhaseFDA-approved

Mechanism of action

This inactivated influenza vaccine contains viral antigens (typically hemagglutinin and neuraminidase from H1N1 strain) that trigger both humoral and cell-mediated immune responses. Upon vaccination, B cells produce neutralizing antibodies against the virus, while T cells develop memory to recognize and eliminate infected cells, providing protection against H1N1 infection.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Anti-pandemic H1N1 influenza vaccine

What is Anti-pandemic H1N1 influenza vaccine?

Anti-pandemic H1N1 influenza vaccine is a inactivated influenza vaccine drug developed by University of Sao Paulo, indicated for Prevention of H1N1 influenza infection during pandemic periods.

How does Anti-pandemic H1N1 influenza vaccine work?

The vaccine stimulates the immune system to produce antibodies and cellular immunity against H1N1 influenza virus antigens.

What is Anti-pandemic H1N1 influenza vaccine used for?

Anti-pandemic H1N1 influenza vaccine is indicated for Prevention of H1N1 influenza infection during pandemic periods.

Who makes Anti-pandemic H1N1 influenza vaccine?

Anti-pandemic H1N1 influenza vaccine is developed and marketed by University of Sao Paulo (see full University of Sao Paulo pipeline at /company/university-of-sao-paulo).

What drug class is Anti-pandemic H1N1 influenza vaccine in?

Anti-pandemic H1N1 influenza vaccine belongs to the inactivated influenza vaccine class. See all inactivated influenza vaccine drugs at /class/inactivated-influenza-vaccine.

What development phase is Anti-pandemic H1N1 influenza vaccine in?

Anti-pandemic H1N1 influenza vaccine is FDA-approved (marketed).

What are the side effects of Anti-pandemic H1N1 influenza vaccine?

Common side effects of Anti-pandemic H1N1 influenza vaccine include Injection site pain, redness, or swelling, Fever, Myalgia, Fatigue, Headache.

Related